Celularity Inc. announced that it has entered into a securities purchase agreement with an existing investor Dragasac Limited to issue 21,410,983 shares of Class A common stock, par value $0.0001 per share at a price of $0.24898 per share for the gross proceeds of $5,330,906.54734 and 5,352,746 accompanying warrants at a price of $0.125 per accompanying PIPE Warrant for gross proceeds of $669,093.25; for total gross proceeds of $5,999,999.79734 on January 12, 2024. Each PIPE Warrant has an exercise price of $0.24898 per share, is immediately exercisable, will expire on January 16, 2029 and is subject to customary adjustments for certain transactions. The securities were issued pursuant to an exemption from registration provided for under Section 4(a)(2) of the Securities Act of 1933, as amended, or the Act, and Regulation D promulgated thereunder.